NUCLEUS Q2 : CONS NET PROFIT DOWN 31.3% AT ₹19.12 CR (YOY), DOWN 16.7% (QOQ). WEAK (ON 1ST LOOK)

Revenue up 6.0% at ₹208.09 Cr (YOY), up 7.4% (QOQ). Ebitda down 28.4% at ₹28.89 Cr (YOY), up 19.9% (QOQ); margins 13.9% v 20.6% (YOY), 12.4% (QOQ). Caution: Jun 2026 included a ₹9.82 Cr exceptional credit; Sep 2026 had no exceptional item.

Nucleus Software Exports Limited

Open attachment

← Back to feed